PURPOSE: In pancreatic cancer, the presence of peritoneal carcinomatosis (PC) precludes the possibility of a surgical cure, irrespective of the resectability of the primary tumor. However, peritoneal spread cannot be reliably detected radiographically during preoperative tumor staging. METHODS: The pancreatic adenocarcinoma database of the Tübingen Comprehensive Cancer Center included 29 patients in whom PC was incidentally detected during the surgery. These patients were retrospectively compared for patient- and tumor-related factors with 29 randomly selected patients without PC who underwent curative resection. RESULTS: Clinical jaundice and diarrhea were more frequently present in patients without PC. The CA 19-9 levels were significantly higher in patients with PC compared to those in patients without PC. No other differences were observed in the patient- or tumor-related factors between the two groups. CONCLUSION: In pancreatic cancer patients, markedly elevated CA 19-9 levels may serve as surrogate marker for peritoneal dissemination, irrespective of the local resectability of the tumor. In such patients, laparoscopy should be considered as an additional staging tool to rule out peritoneal carcinomatosis.
PURPOSE: In pancreatic cancer, the presence of peritoneal carcinomatosis (PC) precludes the possibility of a surgical cure, irrespective of the resectability of the primary tumor. However, peritoneal spread cannot be reliably detected radiographically during preoperative tumor staging. METHODS: The pancreatic adenocarcinoma database of the Tübingen Comprehensive Cancer Center included 29 patients in whom PC was incidentally detected during the surgery. These patients were retrospectively compared for patient- and tumor-related factors with 29 randomly selected patients without PC who underwent curative resection. RESULTS: Clinical jaundice and diarrhea were more frequently present in patients without PC. The CA 19-9 levels were significantly higher in patients with PC compared to those in patients without PC. No other differences were observed in the patient- or tumor-related factors between the two groups. CONCLUSION: In pancreatic cancerpatients, markedly elevated CA 19-9 levels may serve as surrogate marker for peritoneal dissemination, irrespective of the local resectability of the tumor. In such patients, laparoscopy should be considered as an additional staging tool to rule out peritoneal carcinomatosis.
Authors: M E van Rossen; L J Hofland; M P van den Tol; P M van Koetsveld; J Jeekel; R L Marquet; C H van Eijck Journal: J Pathol Date: 2001-04 Impact factor: 7.996
Authors: S Ten Raa; S J Oosterling; N P van der Kaaij; M P van den Tol; R H J Beelen; S Meijer; C H J van Eijck; J R M van der Sijp; M van Egmond; J Jeekel Journal: J Surg Oncol Date: 2005-11-01 Impact factor: 3.454
Authors: Carlo M Contreras; Eric J Stanelle; John Mansour; J Louis Hinshaw; Layton F Rikkers; Robert Rettammel; David M Mahvi; Clifford S Cho; Sharon M Weber Journal: J Surg Oncol Date: 2009-12-15 Impact factor: 3.454
Authors: M P van den Tol; S ten Raa; W M U van Grevenstein; M E E van Rossen; J Jeekel; C H J van Eijck Journal: Dig Surg Date: 2007-08-29 Impact factor: 2.588
Authors: Ingmar Königsrainer; Derek Zieker; Stefan Beckert; Claus von Weyhern; Stefan Löb; Claudius Falch; Björn L Brücher; Alfred Königsrainer; Jörg Glatzle Journal: Cell Physiol Biochem Date: 2009-05-06